Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Yellow Fever Vaccine”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Large-scale testing (Phase 3)Looking for participantsNCT07103148
What this trial is testing

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

Who this might be right for
Yellow Fever Immunization
Sanofi 2,440
Early research (Phase 1)Study completedNCT05172544
What this trial is testing

Trial of an Inactivated Yellow Fever Virus Vaccine

Who this might be right for
Yellow Fever
Najit Technologies, Inc. 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04942210
What this trial is testing

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA

Who this might be right for
Yellow FeverHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 568
Post-approval studies (Phase 4)Study completedNCT02991495
What this trial is testing

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)

Who this might be right for
Yellow Fever
Epicentre 1,630
Not applicableStudy completedNCT03458780
What this trial is testing

Yellow Fever Immune Response at Single Cell Resolution

Who this might be right for
Healthy
Rockefeller University 6
Large-scale testing (Phase 3)Study completedNCT07002060
What this trial is testing

Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

Who this might be right for
Yellow Fever Immunization
Sanofi 640
Large-scale testing (Phase 3)Study completedNCT05421611
What this trial is testing

SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

Who this might be right for
Yellow Fever
Serum Institute of India Pvt. Ltd. 1,824
Testing effectiveness (Phase 2)Study completedNCT01488890
What this trial is testing

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 390
Post-approval studies (Phase 4)Study completedNCT05374317
What this trial is testing

Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

Who this might be right for
Yellow Fever Vaccination Reaction
US Army Medical Research Institute of Infectious Diseases 88
Not applicableStudy completedNCT03430388
What this trial is testing

Yellow Fever Vaccine in Patients With Rheumatic Diseases

Who this might be right for
Systemic LupusRheumatoid ArthritisSpondyloarthritis+8 more
University of Sao Paulo General Hospital 600
Post-approval studies (Phase 4)Looking for participantsNCT06148025
What this trial is testing

Antibiotics and Vaccine Immune Responses Study

Who this might be right for
Vaccine Response Impaired
South Australian Health and Medical Research Institute 348
Post-approval studies (Phase 4)Study completedNCT03725618
What this trial is testing

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

Who this might be right for
Yellow Fever
Centers for Disease Control and Prevention 1,788
Testing effectiveness (Phase 2)Study completedNCT00788151
What this trial is testing

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 300
Not applicableStudy completedNCT03591003
What this trial is testing

"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

Who this might be right for
HIV InfectionsYellow Fever Vaccine
Centre Hospitalier Universitaire Saint Pierre 200
Testing effectiveness (Phase 2)Study completedNCT00730288
What this trial is testing

Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi 35
Testing effectiveness (Phase 2)Study completedNCT03116802
What this trial is testing

Yellow Fever Vaccine on Statin/ Non Statin Subjects

Who this might be right for
Yellow Fever VaccineYellow Fever
Singapore General Hospital 37
Post-approval studies (Phase 4)Looking for participantsNCT03132311
What this trial is testing

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals

Who this might be right for
HIV Infections
Oswaldo Cruz Foundation 400
Testing effectiveness (Phase 2)Study completedNCT00436007
What this trial is testing

Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen

Who this might be right for
Malaria
GlaxoSmithKline 511
Not applicableStudy completedNCT02572518
What this trial is testing

Immunity After Two Doses of Yellow Fever Vaccine

Who this might be right for
Yellow Fever
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 440
Large-scale testing (Phase 3)Study completedNCT02699099
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 699
Load More Results